N-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide

C19H23N6O5S+ — CID 159090891

IUPACN-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide
SMILESCc1ccc(OC2CCN(C(=O)n3ccc(NS(C)(=O)=O)n3)CC2)cc1-[n+]1cnco1
InChIInChI=1S/C19H23N6O5S/c1-14-3-4-16(11-17(14)25-12-20-13-29-25)30-15-5-8-23(9-6-15)19(26)24-10-7-18(21-24)22-31(2,27)28/h3-4,7,10-13,15H,5-6,8-9H2,1-2H3,(H,21,22)/q+1
InChIKeyXFPNVNVEWDSJMA-UHFFFAOYSA-N
MW447.50 g/mol
LogP1.34
Rot. Bonds5

About N-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide

N-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide (PubChem CID 159090891) has the molecular formula C19H23N6O5S+ and a molecular weight of 447.50 g/mol. Its IUPAC name is N-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide.

Molecular Properties

Compound NameN-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide
PubChem CID159090891
Molecular FormulaC19H23N6O5S+
Molecular Weight447.50 g/mol
Exact Mass447.14
IUPAC NameN-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide
SMILESCc1ccc(OC2CCN(C(=O)n3ccc(NS(C)(=O)=O)n3)CC2)cc1-[n+]1cnco1
InChIInChI=1S/C19H23N6O5S/c1-14-3-4-16(11-17(14)25-12-20-13-29-25)30-15-5-8-23(9-6-15)19(26)24-10-7-18(21-24)22-31(2,27)28/h3-4,7,10-13,15H,5-6,8-9H2,1-2H3,(H,21,22)/q+1
InChIKeyXFPNVNVEWDSJMA-UHFFFAOYSA-N
XLogP1.34
TPSA123.44 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500447.50
LogP ≤ 51.34
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze N-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide?
The IUPAC name of N-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide (CID 159090891) is N-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide.
What is the SMILES notation for N-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide?
The canonical SMILES for N-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide is Cc1ccc(OC2CCN(C(=O)n3ccc(NS(C)(=O)=O)n3)CC2)cc1-[n+]1cnco1.
What is the InChIKey of N-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide?
The InChIKey is XFPNVNVEWDSJMA-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H23N6O5S/c1-14-3-4-16(11-17(14)25-12-20-13-29-25)30-15-5-8-23(9-6-15)19(26)24-10-7-18(21-24)22-31(2,27)28/h3-4,7,10-13,15H,5-6,8-9H2,1-2H3,(H,21,22)/q+1.
What are the key properties of N-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide?
N-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide has a molecular weight of 447.50 g/mol, XLogP of 1.34, 5 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[4-[4-methyl-3-(1,2,4-oxadiazol-2-ium-2-yl)phenoxy]piperidine-1-carbonyl]pyrazol-3-yl]methanesulfonamide is sourced from PubChem (CID 159090891), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).